Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

437
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
437
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

248
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
248
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

287
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
287
Pneumothorax-I01:26

Pneumothorax-I

1.1K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.1K
Pneumothorax-II01:27

Pneumothorax-II

788
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
788
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

240
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
240

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.

Thrombosis and haemostasis·2026
Same author

Association of Obesity With Mortality and Bleeding in Cancer-Associated Venous Thromboembolism.

Mayo Clinic proceedings·2026
Same author

Intermediate-dose anticoagulation in COVID-19: closing the loop on a long-settled question.

Journal of thrombosis and haemostasis : JTH·2026
Same author

A simple score to identify the sickest normotensive patients with acute pulmonary embolism.

ERJ open research·2026
Same author

Pulmonary embolism epidemiology: trends, risk factors, comorbidities, and clinical implications.

European heart journal·2026
Same author

Development and external validation of an international score to predict cancer 1 year after venous thromboembolism.

European journal of internal medicine·2026
Same journal

Venous Thromboembolism Prophylaxis and Postoperative Outcomes in Persons with Bleeding Disorders Undergoing Major Surgery: A Canadian Pilot Feasibility Study.

TH open : companion journal to thrombosis and haemostasis·2026
Same journal

Combined Effect of Hemoglobin Levels and Obesity on the Risk of Incident Venous Thromboembolism: The Tromsø Study.

TH open : companion journal to thrombosis and haemostasis·2026
Same journal

Edoxaban versus Apixaban Outcomes Differences in 8,444 Patients with Atrial Fibrillation from Italy: A Real-World Use Comparison.

TH open : companion journal to thrombosis and haemostasis·2026
Same journal

Cross-Reactivity of Antiphospholipid Antibodies with Gut Commensal Proteins in Antiphospholipid Syndrome.

TH open : companion journal to thrombosis and haemostasis·2026
Same journal

Individual Comparative PK Evaluation of Single-dose Octocog Alfa, Rurioctocog Alfa Pegol, and Efanesoctocog Alfa in Adults with Severe Hemophilia A.

TH open : companion journal to thrombosis and haemostasis·2026
Same journal

Differential Regulation of Granule Release in Platelets and Immune Cells.

TH open : companion journal to thrombosis and haemostasis·2026
See all related articles

Related Experiment Video

Updated: Jan 2, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

725

Intermediate-High Risk Pulmonary Embolism.

Rosa Mirambeaux1, Francisco León1, Behnood Bikdeli2,3,4

  • 1Respiratory Department, Ramon y Cajal Hospital, Madrid, Spain.

TH Open : Companion Journal to Thrombosis and Haemostasis
|December 10, 2019
PubMed
Summary
This summary is machine-generated.

Intermediate-high risk pulmonary embolism (PE) affects about 10% of patients and has high mortality. Normalizing heart rate (HR) within 48 hours may predict a low risk of deterioration.

Keywords:
intermediate-high riskprognosispulmonary embolismsurvival

More Related Videos

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

705
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

488

Related Experiment Videos

Last Updated: Jan 2, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

725
Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

705
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

488

Area of Science:

  • Cardiology
  • Pulmonology
  • Critical Care Medicine

Background:

  • Acute pulmonary embolism (PE) poses significant risks, particularly for intermediate-high risk patients.
  • Limited data exists on the specific prevalence, management strategies, and clinical outcomes for this patient subgroup.

Purpose of the Study:

  • To investigate the prevalence, management, and 30-day outcomes of intermediate-high risk acute pulmonary embolism patients.
  • To identify early indicators of clinical stability and risk stratification in these patients.

Main Methods:

  • Prospective cohort study of 1,015 normotensive acute PE patients over 4 years.
  • Assessed intermediate-high risk PE prevalence (9.6%).
  • Monitored 30-day PE-related mortality and complicated course, with serial measurements of SBP, HR, BNP, cTnI, and echocardiography within 48 hours.

Main Results:

  • Intermediate-high risk PE occurred in 9.6% of patients, with 24% experiencing a complicated course and 7.2% mortality within 30 days.
  • Normalization of heart rate (HR) within 48 hours in survivors not receiving immediate thrombolysis was associated with a significantly lower risk (1.4%) of a complicated course between days 2-30.

Conclusions:

  • Intermediate-high risk PE is associated with substantial morbidity and mortality.
  • Early normalization of heart rate (HR) 48 hours post-diagnosis may identify patients with a very low risk of subsequent clinical deterioration.